Skip to main content
. 2023 Jul 31;29(8):2133–2141. doi: 10.1038/s41591-023-02465-7

Extended Data Table 3.

Anti-tumor activity in the ITT population assessed by investigator

graphic file with name 41591_2023_2465_Tab3_ESM.jpg

a Per RECIST version 1.1.

b Patients with missing data had no post-baseline imaging assessment.

c DOR is reported among patients with an objective response.

BOR, best overall response; CR, complete response; ND, no disease; NE, not evaluable; No., number; PD, progressive disease; PR, partial response; SD, stable disease.